40
Participants
Start Date
August 24, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
June 30, 2026
Nintedanib
For patients with unresectable NSCLC, nidanib is administered during sequential radiotherapy
RECRUITING
Jincheng General Hospital, Jincheng
RECRUITING
Jinzhong third people's hospital, Jinzhong
RECRUITING
Frist Hospital of Shanxi Medical University, Taiyuan
RECRUITING
Second Hospital of Shanxi Medical University, Taiyuan
RECRUITING
Shanxi Bethune Hospital, Taiyuan
RECRUITING
Shanxi Hospital of Traditional Chinese Medicine, Taiyuan
RECRUITING
TISCO General Hospital, Taiyuan
Second Hospital of Shanxi Medical University
OTHER